Predicting Success in the Endoscopic Management of Pediatric Vesicoureteral Reflux

• Published in: Urology (Ridgewood, N.J.) Vol. 76; no. 1; pp. 195 - 198
• Main Authors: Routh, Jonathan C, Reinberg, Yuri
• Format: Journal Article
• Language: English
• Published: New York, NY Elsevier Inc 01.07.2010; Elsevier
• Subjects: Biological and medical sciences; Cystoscopy; Dextrans - administration & dosage; Humans; Hyaluronic Acid - administration & dosage; Medical sciences; Nephrology. Urinary tract diseases; Prognosis; Remission Induction; Urinary system involvement in other diseases. Miscellaneous; Urinary tract. Prostate gland; Urology; Vesico-Ureteral Reflux - therapy; Human; Pediatrics; Nephrology; Urinary system disease; Clinical management; Vesicoureteral reflux; Bladder disease; Urinary tract disease; Endoscopy; Child; Urology
• ISSN: 0090-4295; 1527-9995
• DOI: 10.1016/j.urology.2009.09.017

Vesicoureteral reflux is a common cause of pediatric morbidity. Though traditionally managed using a limited number of therapeutic modalities, the last decade has witnessed countless surgical innovations for treating reflux. A major force behind this innovation is the increasing use of endoscopic injection, which currently constitutes nearly half of all anti-reflux procedures performed in the United States. However, published success rates for injection vary dramatically. Despite a relative lack of comparative data, multiple studies have attempted to define the most important prognostic factors for injection success. This article is an attempt to summarize these findings.